Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Povidone Iodine and Cesarean Section Wound Infections

This study has been completed.
Information provided by (Responsible Party):
Mohammed Khairy Ali, Assiut University Identifier:
First received: October 3, 2012
Last updated: NA
Last verified: October 2012
History: No changes posted

The aim of this randomized clinical trial is to compare the efficiency of hand scrubbing by Povidone-Iodine solution 10% over 7.5% concentration in decreasing post-cesarean section wound infections & compare side effects of both agents.

Condition Intervention Phase
Wound Infections
Drug: Povidone Iodine 10% vand cesarean section wound infections
Drug: Povidone Iodine 7.5% vand cesarean section wound infections
Phase 3

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Single Group Assignment
Masking: Single Blind (Subject)
Primary Purpose: Prevention
Official Title: Povidone Iodine 10% Versus 7.5% Hand Scrub and Cesarean Section Wound Infections: A Randomized Trial

Resource links provided by NLM:

Further study details as provided by Assiut University:

Primary Outcome Measures:
  • The difference of incidence of surgical site infection between both groups [ Time Frame: 4 month ] [ Designated as safety issue: Yes ]
    Determine the difference in incidence of surgical site infection between Povidone Iodine 10% versus 7.5% hand scrub

Secondary Outcome Measures:
  • The difference in the side effects between both groups e.g. dermatitis [ Time Frame: 4 month ] [ Designated as safety issue: Yes ]
    Determine the difference in incidence of side effects between Povidone Iodine 10% versus 7.5% hand scrub

Enrollment: 3231
Study Start Date: January 2012
Study Completion Date: May 2012
Primary Completion Date: April 2012 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Povidone Iodine 10%
Using Povidone Iodine 10% hand scrub before caesarian section
Drug: Povidone Iodine 10% vand cesarean section wound infections
Experimental: Povidone Iodine 7.5% hand scrub
Using Povidone Iodine 7.5% hand scrub before caesarian section
Drug: Povidone Iodine 7.5% vand cesarean section wound infections

Detailed Description:

For centuries, hand washing with soap and water has been considered the main approach for personal hygiene. In the community, hand hygiene has been known to prevent infectious diseases and to decrease the burden of disease. Currently, hand hygiene is considered the most important measure for preventing the spread of pathogens in health-care settings.

There are multiple agents used for surgical hand scrubbing as alcohol, chlorhexidine, iodine/iodophors, para-chloro-meta-xylenol & triclosan. Ideally, the optimum antiseptic used for scrub should have broad spectrum of activity, persistent effect & fast acting. Unfortunately most studies evaluating surgical scrub antiseptics have focused on measuring hand bacterial colony counts. No randomized clinical trials have evaluated the impact of surgical scrub choice on surgical site infection risk & proven its efficiency.


Ages Eligible for Study:   18 Years to 40 Years
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • elective caesarian section (CS)

Exclusion Criteria:

  • diabetes,
  • immuno-compromised patients
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01700803

Women Health Hospital - Assiut university
Assiut, Egypt, 71111
Sponsors and Collaborators
Assiut University
  More Information

No publications provided

Responsible Party: Mohammed Khairy Ali, Principal Investigator, Assiut University Identifier: NCT01700803     History of Changes
Other Study ID Numbers: Betadine CS
Study First Received: October 3, 2012
Last Updated: October 3, 2012
Health Authority: Egypt: Institutional Review Board

Keywords provided by Assiut University:
Povidine Iodine
Hand scrubbing
Cesarean section wound infections
post cesarean section

Additional relevant MeSH terms:
Communicable Diseases
Wound Infection
Wounds and Injuries
Cadexomer iodine
Anti-Infective Agents
Anti-Infective Agents, Local
Blood Substitutes
Growth Substances
Hematologic Agents
Pharmacologic Actions
Physiological Effects of Drugs
Plasma Substitutes
Therapeutic Uses
Trace Elements processed this record on February 27, 2015